Expansion of SCG/GCG-Based CAD Sceering: Inclusion of Healthy Controls and CCTA Patients

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1600 participants.

Also called NCT06880133

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose screening
Phase
Not applicable
Enrolled
  • 1,600 participants (enrolled count) (from the registry)
Sponsor
Heart Force Medical Inc. (from the registry)
Registry
  • NCT NCT06880133
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Uzbekistan (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT06880133. Allocation not applicable; no masking; primary purpose screening. Start 2021-11-12 (actual); primary completion 2023-12-26 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Expansion of SCG/GCG-Based CAD Sceering: Inclusion of Healthy Controls and CCTA Patients
Acronym
HF-CAD-CCTA
Condition
Coronary Artery Disease (CAD (coronary artery disease)) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD))
Intervention (Device)
Seismocardiography (SCG) and Gyrocardiography (GCG) Screening
Lead sponsor
Heart Force Medical Inc. (class: industry)

Record details

Record id
cardio:ct-nct06880133
Content hash
fc2053a166b92e4ca4d0754351a31230fcbd908114230c5dc3a6edd530ac6452